Company responds to sale rumours

Posted 1 April 2026 AM

Italian pharma Recordati Rare Disease has been forced to respond to swirling speculation that the company is being sold - admitting there is in fact an offer on the table.

In a statement, the company - which is headquartered in Milan but has about 150 offices around the world, including in Australia - said the offer from private equity firm CVC Capital Partners had not yet been reviewed.

To see the whole article please log in.

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

Not a member? Sign up here